IL-33 reduces the development of atherosclerosis.

IL-33 reduces the development of atherosclerosis.
复制标题

DOI:
10.1084/jem.20071868
复制
发表时间:
2008-02-18
期刊:
The Journal of experimental medicine
影响因子:
--
通讯作者:
Liew FY
Liew FY
中科院分区:
其他
文献类型:
--
作者:
Miller AM;Xu D;Asquith DL;Denby L;Li Y;Sattar N;Baker AH;McInnes IB;Liew FY

文献摘要

参考文献

被引文献

相似文献

动脉粥样硬化是血管系统的慢性炎症性疾病,通常导致心肌梗死和中风。我们发现,IL-33,这是一种新的IL-1样细胞因子,通过ST 2信号,可以减少高脂饮食ApoE−/−小鼠动脉粥样硬化的发展。IL-33和ST 2存在于小鼠和人的正常和动脉粥样硬化血管系统中。尽管对照PBS处理的小鼠在主动脉窦中形成严重的和发炎的动脉粥样硬化斑块,但在IL-33处理的动物中病变发展显著减少。IL-33还显著增加血清和淋巴结细胞中IL-4、IL-5和IL-13的水平,但降低IFNγ的水平。IL-33治疗还升高了总血清伊加、IgE和IgG 1的水平,但降低了IgG 2a,这与Th 1至Th 2的转换一致。IL-33治疗的小鼠也产生了显着升高的抗氧化低密度脂蛋白(ox-LDL)抗体。相反,与对照IgG处理的小鼠相比,用可溶性ST 2(一种中和IL-33的诱饵受体)处理的小鼠在ApoE−/−小鼠的主动脉窦中形成了显著更大的动脉粥样硬化斑块。此外,抗IL-5 mAb与IL-33共同给药可防止斑块大小减小,并减少IL-33诱导的ox-LDL抗体量。结论:IL-33可能通过诱导IL-5和ox-LDL抗体在动脉粥样硬化的发展中发挥保护作用。
Atherosclerosis is a chronic inflammatory disease of the vasculature commonly leading to myocardial infarction and stroke. We show that IL-33, which is a novel IL-1–like cytokine that signals via ST2, can reduce atherosclerosis development in ApoE−/− mice on a high-fat diet. IL-33 and ST2 are present in the normal and atherosclerotic vasculature of mice and humans. Although control PBS-treated mice developed severe and inflamed atherosclerotic plaques in the aortic sinus, lesion development was profoundly reduced in IL-33–treated animals. IL-33 also markedly increased levels of IL-4, -5, and -13, but decreased levels of IFNγ in serum and lymph node cells. IL-33 treatment also elevated levels of total serum IgA, IgE, and IgG1, but decreased IgG2a, which is consistent with a Th1-to-Th2 switch. IL-33–treated mice also produced significantly elevated antioxidized low-density lipoprotein (ox-LDL) antibodies. Conversely, mice treated with soluble ST2, a decoy receptor that neutralizes IL-33, developed significantly larger atherosclerotic plaques in the aortic sinus of the ApoE−/− mice compared with control IgG-treated mice. Furthermore, coadministration of an anti–IL-5 mAb with IL-33 prevented the reduction in plaque size and reduced the amount of ox-LDL antibodies induced by IL-33. In conclusion, IL-33 may play a protective role in the development of atherosclerosis via the induction of IL-5 and ox-LDL antibodies.
DOI: 10.1038/nm1343
发表时间: 2006-02-01
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
Ait-Oufella, H;Salomon, BL;Mallat, Z
通讯作者: Mallat, Z
DOI: 10.1172/jci30634
发表时间: 2007-06-01
影响因子: 15.9
作者:
Sanada, Shoji;Hakuno, Daihiko;Lee, Richard T.
通讯作者: Lee, Richard T.
DOI: 10.1161/01.cir.0000127958.21003.5a
发表时间: 2004-05-11
期刊: CIRCULATION
影响因子: 37.8
作者:
Shimpo, M;Morrow, DA;Lee, RT
通讯作者: Lee, RT
DOI: 10.1172/jci200420479
发表时间: 2004-08-01
影响因子: 15.9
作者:
Binder, CJ;Hartvigsen, K;Witztum, JL
通讯作者: Witztum, JL
DOI: 10.1016/0140-6736(92)90926-t
发表时间: 1992-04-11
期刊: LANCET
影响因子: 168.9
作者:
SALONEN, JT;YLAHERTTUALA, S;WITZTUM, JL
通讯作者: WITZTUM, JL